http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19851617-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c644138f2071b48b5991a1425d8dde0a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 1998-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f9bb34beacbafa7306d09a29459be71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4e0ca889321e8cd3667dbe099b28f36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9943c1aca8b426909d3075e18753233c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6362642ecc9b732f8290a0e3d73a45b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28594c352dae2c63fee885b5eccc6665
publicationDate 2000-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-19851617-A1
titleOfInvention Treatment set
abstract The invention describes a set for the treatment of IRDS, ALI or ARDS, comprising a first container which has a volume of 50 to 500 ml and contains a pulverulent pulmonary surfactant preparation, the amount of phospholipids in the container being 50 to 500 mg and one second container, which has a volume of 50 to 500 ml and contains a pulverulent pulmonary surfactant preparation, the amount of phospholipids in the second container being 1 to 10 g.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006013183-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8236750-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-10018022-A1
priorityDate 1998-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21841
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID50683
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22398
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A3Q2TU36
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6440
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6138
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22397
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521634
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11685
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20389
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8206
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A6I8PPP7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15785
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP55152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414862906
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID452110
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35245

Total number of triples: 38.